Skip to content
Pharma Observatory a Scientist.com platform

CRO operations and CRO business development

Find sponsors starting programs where your CRO has a record

See your trials the way a sponsor's outsourcing team sees them, then find the sponsors active in your strongest indications.

Individual plan, $249/seat/mo. Card required.

The Clinical Research Map: a world map of clustered research sites beside filters for supplier, country and site type, with counts of CROs mapped and sites geocoded
The Clinical Research Map: CROs named on trials, drawn by site location, with filters for country and site type. Captured from production data on 2026-10-10.

The problem today

Prospecting lists come from conference badges and press releases, so the same sponsors hear from every CRO. Your own track record is scattered across registry entries that rarely name the CRO. When a bid defense asks for experience in the indication, the evidence takes days to assemble.

Why this beats what you do now

  • Prospects chosen by fit. Start from sponsors active in the indications where you have a record.
  • Your record, as buyers see it. See what the public registries show for your organization before a sponsor does.
  • Evidence for the bid defense. Trials behind a ranking open from the leaderboard, ready to cite.
  • One seat to start. The Individual plan is published at $249/seat/mo and starts with a 14-day trial.

What you can answer

Pages marked free open without an account. The rest open in the product, starting with a 14-day trial.

How active is an indication?

Condition pages count the registered trials in a disease by phase and by start year, which shows whether an indication is gaining or losing activity before you spend prospecting time on it. The lead sponsors listed there are candidate prospects. 3,859 registered trials study Alzheimer Disease or one of its sub-conditions.

Free to read Conditions Open the Alzheimer Disease page

Where does our delivered record run deepest?

The Clinical Research Map leaderboard ranks contract-research vendors by distinct trials in a cut you choose: indication, phase, country or region, and start year. Each row shows the vendor's most recent trial year, its countries and how it was matched to the trials.

In the product: Clinical Research Map

How does a sponsor see our record?

Each leaderboard row opens to the vendor's company page and draws its delivered-trial footprint on the map. The data is ClinicalTrials.gov sponsor and collaborator records matched to the vendor, and a notice states how many trials in your cut name a vendor at all.

In the product: Clinical Research Map

Which drugs are in development in our indications?

The Program explorer lists development programs as drug and indication pairs and filters them by the highest phase reached. Search an indication to see which drugs are in development there.

In the product: Programs

Which vendors and sites does the Scientist.com network hold?

Suppliers lists the vendors and CROs in the Scientist.com network with their footprint, and shows which of them also appear as clinical-trial sponsors. Each supplier page carries its sites.

In the product: Suppliers

Which sponsors have programs in development?

A company page lists its programs under In development, Approved and Abandoned, with the trials behind each. A prospect's active work is visible before the first call.

In the product: Companies

Scope

Trial registries name a CRO on only part of their studies, and the Clinical Research Map matches vendors to trials as sponsor or collaborator. The leaderboard states how many trials in your selection name a vendor at all.

Build one prospect list during the trial

Every answer above marked "In the product" opens with the Individual plan.

See all plans

Individual plan, $249/seat/mo, card required.

See the other teams